Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telmiluv 40mg Tablet

Prescription Icon
Prescription Required

Marketer

Amwin Pharmaceuticals

Salt Composition

Telmisartan (40mg)

Overview Telmiluv 40mg Tablet

CardioGuard 40mg tablets manage hypertension and congestive heart failure. Reducing blood pressure minimizes the risk of future strokes and myocardial infarctions. This medication also protects renal function in diabetic patients. CardioGuard 40mg may be used alone or alongside other medications, taken with or without food, morning or night; consistent daily timing maximizes efficacy. Continuous use is crucial, even with controlled blood pressure or feeling well; discontinuation risks condition exacerbation. It's a widely prescribed, safe medication for long-term management. Lifestyle adjustments – including regular physical activity, weight loss, smoking cessation, moderate alcohol consumption, and reduced dietary sodium as directed by your physician – further support blood pressure control. Generally well-tolerated, potential side effects like hypotension (low blood pressure) are infrequent. Report any side effects; dosage adjustment or alternative medication may be considered. Prior to initiating treatment, disclose any kidney or liver conditions, and pregnant or nursing individuals should consult their doctor. Regular monitoring of kidney function, blood pressure, and serum potassium levels may be undertaken during treatment.

Uses of Telmiluv 40mg Tablet

Managing high blood pressure | Addressing heart failure | Reducing fever | Preventing cardiovascular events

Major Benefits of Telmiluv 40mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmiluv 40mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Telmiluv 40mg Tablet:

  • Diarrhea
  • Upper respiratory tract infection
  • Back pain
  • Sinus inflammation
  • Skin ulcer
  • Intermittent claudication

How to use Telmiluv 40mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmiluv 40mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.

How Telmiluv 40mg Tablet works:

Telmiluv 40mg tablets function as an angiotensin receptor blocker, or ARB. By inhibiting a vasoconstricting substance, the medication promotes vasodilation. This reduces blood pressure, improving blood flow throughout the body and enhancing cardiac efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Telmiluv 40mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telmiluv 40mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known risks. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Telmiluv 40mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Telmiluv 40mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the use of Telmiluv 40mg Tablets requires careful consideration. Dosage modification of Telmiluv 40mg Tablets might be necessary. Physician consultation is recommended. It is crucial to disclose any pre-existing kidney condition to your doctor. Routine monitoring of blood pressure, creatinine, and potassium levels may be deemed advisable during treatment with this medication.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Telmiluv 40mg tablets, potentially requiring dosage modification under medical supervision. Telmiluv 40mg tablets are contraindicated in patients experiencing severe liver dysfunction.

What if you forget to take Telmiluv 40mg Tablet :

Omit any missed Telmiluv 40mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.

Facts to Know About Telmiluv 40mg Tablet

LabelValue
Type of Compound Benzimiadazole-based compound
Potential for Dependence None.
Type of Treatment HEART

FAQs on Telmiluv 40mg Tablet

A single daily dose of Telmiluv 40mg Tablet, administered either morning or evening, is typically advised. Consistent daily timing aids medication adherence.
Noticeable effects may appear within days, however, optimal results are typically observed after 4 to 8 weeks of therapy.
Discontinue Telmiluv 40mg Tablet only after discussion with your physician, regardless of blood pressure readings. Abrupt cessation can elevate blood pressure, posing potential health risks. Telmiluv 40mg Tablet manages, not cures, hypertension; therefore, continuous use may be necessary. Consult your doctor with any questions or worries.
Consult your physician before using Telmiluv 40mg Tablets. Regular monitoring of potassium and creatinine levels may be recommended to assess kidney function. Since Telmiluv 40mg Tablets can potentially impair kidney function, immediately report any edema (swelling of the feet, ankles, or hands) or unexpected weight increase to your doctor.
Rest assured, Telmiluv 40mg Tablets are not associated with weight increase. Animal research indicates Telmiluv 40mg Tablets may even reduce body fat.
Glycemia reduction may occur in diabetic patients using Telmiluv 40mg Tablets. Consequently, consistent blood glucose monitoring is crucial. Diabetic patients should consult their physician, as insulin or other diabetic medication dosages might require modification.
Telmiluv 40mg tablets may elevate blood potassium levels, a condition known as hyperkalemia. Your physician might recommend routine potassium level checks during treatment with this medication.
Telmiluv 40mg tablets do not induce diuresis and are not classified as diuretics. Their mechanism of action involves vasodilation achieved by antagonizing angiotensin II. Angiotensin II elevates blood pressure through vasoconstriction.
Concurrent use of ibuprofen and Telmiluv 40mg tablets necessitates ongoing monitoring of blood pressure and kidney function. Telmiluv 40mg tablets can intensify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in patients using Telmiluv 40mg tablets for congestive heart failure. Ibuprofen might also reduce the antihypertensive efficacy of Telmiluv 40mg tablets.
A single 40mg Telmiluv tablet is typically prescribed for daily use, administered either morning or evening. Maintaining consistent daily timing aids medication adherence.
Noticeable improvement may occur within days, although optimal results typically manifest within four to eight weeks of commencing therapy.
Discontinuing Telmiluv 40mg Tablet without your physician's advice is strongly discouraged, regardless of apparent blood pressure normalization. Abrupt cessation can elevate blood pressure, posing a potential health risk. Telmiluv 40mg Tablet manages, not cures, hypertension; therefore, continuous use may be necessary. Address any questions or worries with your doctor.
Telmiluv 40mg tablets may elevate blood potassium levels, a condition known as hyperkalemia. Your physician might recommend routine blood tests to check your potassium levels during treatment with this medication.
Use of Telmiluv 40mg Tablets should only occur under the guidance of your physician. To track kidney health, your doctor might request periodic blood tests (potassium and creatinine). Since Telmiluv 40mg Tablets can negatively impact kidney function, immediately consult your doctor if you experience edema in your extremities or sudden, unexplained weight increase.
Telmiluv 40mg Tablets are not associated with weight increase. Animal research indicates Telmiluv 40mg Tablets may even reduce body fat.
For individuals with diabetes, Telmiluv 40mg Tablets can reduce blood sugar. Consequently, consistent monitoring of blood glucose is crucial. Diabetic patients should consult their physician as their insulin or other diabetes medication dosage might require modification.
Concurrent use of ibuprofen and Telmiluv 40mg Tablets necessitates regular monitoring of blood pressure and kidney function. Telmiluv 40mg Tablets can intensify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in patients using Telmiluv 40mg Tablets for congestive heart failure. Ibuprofen may reduce the blood pressure-lowering efficacy of Telmiluv 40mg Tablets.
Telmiluv 40mg Tablets do not induce increased urination; they are not diuretics. Their mechanism of action involves vasodilation through the inhibition of angiotensin II, a compound that elevates blood pressure via vasoconstriction.
A single 40mg Telmiluv tablet is typically prescribed for daily use, administered either in the morning or evening. Consistent daily timing aids in medication adherence.
Noticeable improvement might occur within days, however, optimal results are typically observed after four to eight weeks of therapy.
Do not discontinue Telmiluv 40mg Tablet without your physician's advice, regardless of seemingly controlled blood pressure. Abrupt cessation can elevate blood pressure, posing significant health risks. Telmiluv 40mg Tablet manages, not cures, hypertension; therefore, continuous use may be necessary. Discuss any questions or worries with your doctor.
Telmiluv 40mg tablets may elevate blood potassium levels, a condition known as hyperkalemia. Your physician might recommend routine blood tests to track your potassium levels during treatment.
Consult your physician before using Telmiluv 40mg Tablets. Regular monitoring of kidney function, including potassium and creatinine levels, may be recommended by your doctor. Since Telmiluv 40mg Tablets can potentially impair kidney function, promptly inform your doctor if you experience edema in your extremities or unexpected weight increase.
Telmiluv 40mg Tablets are not associated with weight increase; animal research indicates they may even reduce body fat. Therefore, there's no cause for concern regarding weight gain.
Glycemia reduction in diabetic individuals is a potential effect of Telmiluv 40mg Tablets. Consequently, consistent blood glucose monitoring is vital. Diabetic patients should consult their physician, as adjustments to insulin or other diabetes medications may be necessary.
Concurrent use of ibuprofen and Telmiluv 40mg tablets necessitates ongoing monitoring of blood pressure and kidney function. Telmiluv 40mg tablets can amplify ibuprofen's adverse effects, potentially leading to fluid retention, particularly in individuals using Telmiluv 40mg tablets for heart failure. Ibuprofen might reduce the blood pressure-lowering efficacy of Telmiluv 40mg tablets.
Telmiluv 40mg tablets do not induce increased urination; they are not diuretics. Their mechanism of action involves vasodilation achieved by counteracting angiotensin II, a compound that elevates blood pressure through vasoconstriction.
Telmiluv 40mg Tablet
44
MRP 53
16% off